A study at the American Society of Hematology Meeting found that patients with acute myeloid leukemia who achieve remission with Mylotarg have prolonged disease-free survival following stem cell transplantation. Researchers also observed fewer complications from bone marrow transplants compared to traditional treatment.
A Phase III study found significant improvements in overall survival, disease-free status, and complete remission rates for patients with aggressive non-Hodgkin's lymphoma treated with MabThera and CHOP chemotherapy. Survival at 1-year was 83% for the rituximab combination therapy group compared to 68% for those receiving CHOP alone.
A new study by Kent State University psychologist Daniel T. Levin found that people's brains tend to classify faces as belonging to a specific race, rather than recognizing individual features. This 'cross-race recognition deficit' affects people of all racial groups and can lead to inaccurate identifications.